Celularity Inc. (CELU) Trading Update
Celularity Inc. (NASDAQ: CELU) closed the trading session at 02:18 AM Central Europe on Thursday, 22 October 2026 with a price increase of 8.62 % from the previous close. The share price at the session’s close was USD 1.02.
Key Market Metrics
| Metric | Value |
|---|---|
| Shares Outstanding | 32.4 million |
| Market Capitalization | USD 37.6 million |
| 24‑hour Trading Volume | USD 72.7 thousand |
| 200‑day Simple Moving Average | USD 1.10 |
| 52‑Week High | USD 2.55 (27 August 2026) |
| 52‑Week Low | USD 0.56 (30 June 2026) |
Celularity has increased in value by 1.61 % since the end of last month.
24‑Hour Performance of Peer Companies
| Ticker | Current Price | 24‑Hour Change | Market Capitalization |
|---|---|---|---|
| BGSF | USD 4.08 | -1.94 % | USD 44.1 million |
| DRIO | USD 3.68 | -9.13 % | USD 44 million |
| VRM.MX | USD 8.31 | +1.02 % | USD 44.2 million |
| MBBC | USD 14.1 | -1.37 % | USD 44.1 million |
| HYPD | USD 3.10 | +4.02 % | USD 44.4 million |
Company Overview
Celularity Inc. is a clinical‑stage biotechnology firm headquartered in Florham Park, United States. The company focuses on off‑the‑shelf placental‑derived allogeneic cell therapies, including:
- Unmodified natural killer (NK) cells
- Genetically modified NK cells
- Car‑engineered T cells (CAR‑T)
- Mesenchymal‑like adherent stromal cells (ASCs)
Its therapeutic portfolio targets disease areas such as oncology, infectious diseases, and degenerative disorders. Additional information can be found on the company’s website at www.celularity.com . The stock is listed on the Nasdaq exchange.
